Publication | Closed Access

Long-term add-on therapy (compassionate use) with oral artesunate in patients with metastatic breast cancer after participating in a phase I study (ARTIC M33/2)

Metastatic Breast CancerOncologyBreast OncologyMedicineCancer ManagementClinical TrialsBreast CancerPharmacotherapyAnti-cancer AgentCancer TreatmentOral ArtesunatePharmacologyCompassionate Use